What's new

Human medicines European public assessment report (EPAR): Vivlipeg, pegfilgrastim, Status: Opinion

Human medicines European public assessment report (EPAR): Vivlipeg, pegfilgrastim, Status: Opinion

Jun 20, 2025 - 12:25
 0
Human medicines European public assessment report (EPAR): Vivlipeg, pegfilgrastim, Status: Opinion
Human medicines European public assessment report (EPAR): Vivlipeg, pegfilgrastim, Status: Opinion
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Zemcelpro, allogeneic ...

Next Article

Summary of opinion: Darzalex, 19/06/2025 Positive

Related Posts

PSUSA/00010355/202409

PSUSA/00010355/202409

May 27, 2025  0

Human medicines European public assessment report (EPAR): Memantine Merz, memantine hydrochloride, Date of authorisation: 22/11/2012, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR...

Jun 20, 2025  0

Medicine shortage communication (MSC): Fiasp PumpCart a...

May 12, 2025  0